Banque Pictet & Cie’s Amicus Therapeutics FOLD Stock Holding History

Banque Pictet & Cie’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-68,113	Closed	-$755K	–	535
2023 Q1	$755K	Sell	68,113 -30,881	-31%	-$381K	0.01%	413
2022 Q4	$1.21M	Sell	98,994 -31,234	-24%	-$352K	0.01%	375
2022 Q3	$1.36M	Sell	130,228 -24,770	-16%	-$276K	0.01%	351
2022 Q2	$1.67K	Sell	154,998 -14,937	-9%	-$123K	0.02%	335
2022 Q1	$1.61M	Sell	169,935 -49,829	-23%	-$467K	0.01%	377
2021 Q4	$2.54M	Buy	+219,764	New	+$2.45M	0.02%	297

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Banque Pictet & Cie's FOLD Position: Q2 2023 in Review

Banque Pictet & Cie sold out of Amicus Therapeutics (FOLD) in Q2 2023, closing a stake of 68,113 shares — an estimated $755K sold.

Banque Pictet & Cie first reported a position in FOLD in Q4 2021 and held it in 6 quarters. The position peaked at $2.54M in Q4 2021. 216 funds tracked by Wall St. Rank hold FOLD as of Q2 2023.

Banque Pictet & Cie reported no remaining Amicus Therapeutics position as of Q2 2023 after selling out during the quarter.
Banque Pictet & Cie sold 68,113 Amicus Therapeutics shares in Q2 2023, an estimated $755K.
Banque Pictet & Cie first reported a position in Amicus Therapeutics in Q4 2021 and held it in 6 quarters.
Banque Pictet & Cie's Amicus Therapeutics position peaked at $2.54M in Q4 2021.
216 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2023.

Based on Banque Pictet & Cie's 13F filing for Q2 2023, filed 4 Aug 2023.